[1]
MOAMEN ABDELFADIL ISMAIL, MAJED MOHAMMED ALANAZI, BUSHRA F. ALQURASHI, RUBA M. ABUTALEB, YOUSEF FAHAD ALRESHOODI, RIYADH T. IZZZULDEEN, and AMAL ALI M. ALSHEHRI, KHULUD FARHAN ALRUWAILI, DEEMA ALQURASHI, SULTAN AL-DOSARI, ALI ADEL ALESSA, “THE EFFICACY AND SAFETY OF SEMAGLUTIDE IN GLYCEMIC CONTROL, WEIGHT REDUCTION, AND CARDIOVASCULAR RISK MANAGEMENT IN TYPE 2 DIABETES PATIENTS: A SYSTEMATIC REVIEW”, TPM, vol. 32, no. S7 (2025): Posted 10 October, pp. 2234–2241, Nov. 2025.